期刊文献+

血清乳酸脱氢酶及其同工酶在复治多发性骨髓瘤中的临床意义 被引量:5

Clinical Significance of Serum Lactate Dehydrogenase and Its Isoenzymes in the Retreated Patients with Multiple Myeloma
暂未订购
导出
摘要 目的研究血清乳酸脱氢酶(LDH)及其同工酶,M,H亚单位值在复治多发性骨髓瘤(MM)中的临床意义。方法收集复治多发性骨髓瘤患者141例随访资料,分析LDH及其同工酶、亚单位与DS分期、ISS分期、肌酐、骨髓浆细胞数,免疫球蛋白,β2微球蛋白等的关系。结果血清总LDH与DS分期、ISS分期均未见显著联系。LDH1百分比与ISS分期呈显著负相关(P<0.01),LDH4百分比与ISS分期呈显著正相关(P<0.05)。骨髓瘤肾病肾功能不全患者LDH值及LDH4绝对值,H亚单位值与肌酐呈显著正相关(P<0.05)。LDH5百分比及绝对值与骨髓浆细胞数呈显著负相关(P<0.01,P<0.05)。结论对于复治复发性骨髓瘤患者,血清LDH同工酶与ISS分期及肾功损害的程度密切相关,LDH同工酶测定比总LDH活性更具有临床价值。 Objective To investigate the clinical significance of serum lactate dehydrogenase (LDH)and its isoenzymes,M or H subunits in the retreated patients with multiple myeloma(MM). Methods 141 medical records of retreated patients with multiple myeloma were collected,and the relationship of LDH and its isoenzymes,subunits with DS staging system,ISS staging system,creatinine,bone marrow plasma cell percentage,immunoglobulin and microglobin was analyzed. Results Serum total LDH activity was not significantly related to DS staging system and ISS staging system. LDH1 percentages was negatively correlated with ISS staging system(P 〈 0.01),and LDH4 percentages positively associated with ISS staging system (P 〈 0.05). LDH activity,absolute value of LDH1,LDH2,LDH3,LDH4,and H subunits were positively linked to serum creatinine in myeloma kidney disease patients with renal inadequacy (P 〈 0.05). Both percentage and absolute value of LDH5 were negatively correlated with bone marrow plasma cell percentage ( P 〈 0.01 and P 〈 0.05 respectively). ConclusionThe detection of serum LDH isoenzyme is more valuable than total LDH activity in retreated patients with multiple myeloma.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2010年第1期31-33,36,共4页 Journal of China Medical University
基金 辽宁省科技攻关计划项目(2004225004-11)
关键词 乳酸脱氢酶 同工酶 多发性骨髓瘤 lactate dehydrogenase isoenzymes multiple myeloma
  • 相关文献

参考文献12

  • 1Kolev Y,Uetake H,Takagi Y,et al. Lactate dehydrogenase-5 (LDH- 5) expression in human gastric cancer:association with hypoxia-inducible factor (HIF- 1 alpha) pathway, angiogenic factors production and poor prognosis[J].Ann Surg Oncol, 2008,15 ( 8 ) : 2336-2344.
  • 2Kotyza J,Havel D,Kulda V,et al. Differentiated expression of the lactate dehydrogenase subunit M in pleural fluids of neoplastic actiology[J]. Scand J Clin Lab Invest,2009,69( 1 ) :73-78.
  • 3Mohds M,Szigeti N,Marko L,et al. Serum total LDH activity and LDH-2 isozyme in nephrotic syndrome[J]. Kidney Blood Press Res, 2008,31( 1 ) :47-54.
  • 4Adam Z, Pour L, Krejei M, et al. Kidney damage in multiple myeloma and other monoclonal gammopathies [J].Vnitr Lek,2008,54 (9): 847-861.
  • 5Durie Bg, Salmon Se. A clinical staging system for muhiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. [J ]. Cancer, 1975,36 ( 3 ) : 842-854.
  • 6Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma [J]. J Clin Oncol,2005,23 (15):3412- 3420.
  • 7Dumontet C, Drai J, Bienvenu J, et al. Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's Lymphoma [J]. Leukemia, 1999,13(5) :811-817.
  • 8Mazzotta S, Guerranti R, Gozzetti A, et al. Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases : A metabolic adaptation? [J]. Hematology, 2006,11 (4) : 239-244.
  • 9Copur S,Kus S,Kars A,et al. Lactate dehydrogenase and its isoenzymes in serum from patients with multiple myeloma [J].Clin Chem, 1989,35(9): 1968-1970.
  • 10Bouafia F, Drai J, Bienvenu J, et al. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies[ J ]. Bull Cancer, 2004,91 (7-8) : E229-E240.

二级参考文献15

  • 1吴雨洁,李建勇,仇海荣,肖冰,张建富,宋君红.四色流式细胞术分析骨髓增生异常综合征原始细胞免疫表型[J].中国实验血液学杂志,2006,14(1):50-53. 被引量:14
  • 2Durie BG,Salmon SE.A clinical staging system for multiple myeloma.Correlation of measured myeloma cell mass with presenting clinical features,response to treatment and survival.Cancer,1975;36:842-845
  • 3Greipp PR,Sanmiguel GF,Durie BG.A new international staging system (ISS) for multiple myeloma (MM) from the International Myeloma Working Group.Blood,2003; 102:118
  • 4Rawstron AC,Davies FE,DasGupta R,et al.Flow cytometric disease monitoring in multiple myeloma:the relationship between normal and neoplastic plasma cells predicts outcome after transplantation.Blood,2002; 100:3095-3100
  • 5Barlogie B,Shaughnessy J,Tricot G,et al.Treatment of multiple myeloma.Blood,2004; 103:20-32
  • 6Greipp PR,Kumar S.Plasma cell labeling index.Methods Mol Med,2005; 113:25-35
  • 7Garcia-Sanz R,Gonzalez-Fraile M,Mateo G,et al.Proliferative activity of plasma cells is the the most relevant prognostic factor in elderly multiple myeloma patients.Int J Cancer,2004; 112:884-889
  • 8Witzig TE,Kimlinger TK,Ahmann G J,et al.Detection of myeloma cells in the peripheral blood by flow cytometry.Cytometry,1996; 26:113-120
  • 9Nowakowski GS,Witzig TE,Dingli D,et al.Circulating plasma cells detected by flow cytometry as a predictor of survival in 302patients with newly diagnosed multiple myeloma.Blood,2005;106:2276-2279
  • 10Dingli D,Nowakowski GS,Dispenzieri A,et al.Flow cytometric detection of circulating myeloma cells pretransplant in patients with multiple myeloma:a simple risk stratification system.Blood,2006; 107:3384-3388

共引文献4

同被引文献59

引证文献5

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部